NOX2 Protects against Prolonged Inflammation, Lung Injury, and Mortality following Systemic Insults
- 27 April 2013
- journal article
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 5 (6) , 565-580
Abstract
The systemic inflammatory response syndrome (SIRS) is a clinical condition occurring in intensive care unit patients as a consequence of both infectious and noninfectious insults. The mechanisms underlying resolution of SIRS are not well characterized. NOX2 (NADPH oxidase 2)-derived reactive oxygen species are critical for killing of certain pathogens by polymorphonuclear leukocytes (PMN). Patients with chronic granulomatous disease who lack functional NOX2 are not only prone to serious infections, they also exhibit chronic inflammatory conditions, suggesting a local anti-inflammatory role for NOX2. We hypothesized that NOX2 is required for the resolution of sterile systemic inflammation. Using a murine model of sterile generalized inflammation, we observed dramatically increased mortality of gp91(phox-/y) (NOX2-deficient) as compared to wild-type (WT) mice. Both genotypes developed robust SIRS with hypothermia, hypotension, and leukopenia; however, WT mice recovered within 48 h whereas NOX2-deficient mice did not. Although both groups displayed rapid peritoneal PMN recruitment, the recruited NOX2-deficient PMN demonstrated an enhanced inflammatory phenotype. Moreover, NOX2-deficient mice exhibited a hemorrhagic inflammatory response in the lungs with rapid and persistent recruitment of neutrophils to the alveolar space, whereas WT mice had minimal lung pathology. Several proinflammatory cytokines remained elevated in NOX2-deficient mice. The persistent inflammatory environment observed in NOX2-deficient mice resulted from continued peritoneal chemokine secretion and not delayed apoptosis of PMN. These data suggest a requirement for NOX2 in the resolution of systemic inflammation.Keywords
This publication has 38 references indexed in Scilit:
- Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous diseaseClinical and Experimental Immunology, 2011
- Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in miceFree Radical Research, 2011
- NADPH Oxidase Limits Innate Immune Responses in the Lungs in MicePLOS ONE, 2010
- Interleukin-17-Producing γδ T Cells Selectively Expand in Response to Pathogen Products and Environmental SignalsImmunity, 2009
- Constitutive neutrophil apoptosis: Mechanisms and regulationAmerican Journal of Hematology, 2007
- The systemic inflammatory response syndromeMicrobes and Infection, 2006
- The role of oxidative stress in adult critical careFree Radical Biology and Medicine, 2006
- Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. II. Effects on Microbial Proliferation and Host Survival in VivoJournal of Experimental Medicine, 2000
- Chronic Granulomatous Disease: Report on a National Registry of 368 PatientsMedicine, 2000
- Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the ratCritical Care Medicine, 1999